Related Experiment Videos
Pathophysiological basis of the treatment of ischemic heart disease
1I Clinica Medica, II Facoltà di Medicina e Chirurgia, Università degli Studi, Napoli, Italy.
Insights
This review covers ischemic heart disease mechanisms, clinical signs, and treatment goals, focusing on neurohormonal regulation and advances in coronary blood flow. It also discusses reperfusion injury, silent ischemia, and therapies like angioplasty and thrombolysis.
Area of Science:
- Cardiology
- Physiology
- Pharmacology
Background:
- Ischemic heart disease (IHD) encompasses primary and secondary ischemic attacks.
- Understanding IHD requires examining clinical manifestations and treatment objectives.
- Neurohormonal regulation significantly impacts coronary blood flow.
Purpose of the Study:
- To review the primary mechanisms of ischemic attacks.
- To discuss the clinical manifestations and treatment goals for ischemic heart disease.
- To highlight recent advances in understanding and treating IHD, including neurohormonal regulation.
Main Methods:
- Review of existing literature on ischemic heart disease.
- Discussion of neurohormonal regulation of coronary blood flow.
- Analysis of pathophysiological and therapeutic aspects of myocardial reperfusion injury and silent myocardial ischemia.
Main Results:
- Mechanisms of primary and secondary ischemic attacks are detailed.
- Clinical manifestations and treatment goals for IHD are outlined.
- The influence of chemical mediators on coronary circulation is explored.
Conclusions:
- Advances in understanding neurohormonal regulation offer potential for improved IHD treatment.
- Myocardial reperfusion injury and silent myocardial ischemia present significant pathophysiological and therapeutic challenges.
- Coronary angioplasty and thrombolytic therapy represent modern therapeutic approaches for IHD.
Abstract:
In this paper we review the main mechanisms leading to primary and secondary ischemic attacks, the clinical manifestations of ischemic heart disease as well as the goals of treatment. Particular attention is paid to the neurohormonal regulation of coronary blood flow. The most recent advances in this field, achieved in our laboratory too, should permit important progress in the treatment of ischemic disease. The influence of chemical mediators on coronary circulation and the pathophysiological and therapeutic aspects of myocardial reperfusion injury and silent myocardial ischemia are also discussed. Finally, we present our experience with two modern therapeutic approaches to ischemic heart disease: coronary angioplasty and thrombolytic therapy.